Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesc Valldeoriola

Showing results (141-150 of 170) with videos related to

Pageof 17
Sort By:
The Lancet. Neurology|September 18, 2010
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]Alex Iranzo, Francisco Lomeña, Heike Stockner, et al.
Journal of Neuroscience Research|March 21, 2014
Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's diseaseTeresa Botta-Orfila, Xavier Morató, Yaroslau Compta, et al.
Annals of Neurology|August 24, 2017
Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorderAlex Iranzo, Joan Santamaría, Francesc Valldeoriola, et al.
Parkinsonism & Related Disorders|February 13, 2021
Association of PSP phenotypes with survival: A brain-bank studyMar Guasp, Laura Molina-Porcel, Celia Painous, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 11, 2018
Unilateral pallidal stimulation for disabling dystonia due to Rasmussen's diseaseMar Carreño, Maria José Martí, Ibán Aldecoa, et al.
Journal of Neurology|November 9, 2014
Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's diseaseYaroslau Compta, Tony Valente, Josep Saura, et al.
Genes|April 28, 2023
Implementation of Exome Sequencing in Clinical Practice for Neurological DisordersMaría Isabel Alvarez-Mora, Laia Rodríguez-Revenga, Meritxell Jodar, et al.
Journal of Molecular Neuroscience : MN|June 7, 2012
Age at onset in LRRK2-associated PD is modified by SNCA variantsTeresa Botta-Orfila, Mario Ezquerra, Pau Pastor, et al.
Journal of Alzheimer'S Disease : JAD|November 5, 2016
Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1Mariateresa Buongiorno, Francesca Antonelli, Yaroslau Compta, et al.
Parkinsonism & Related Disorders|August 26, 2015
Clinical and imaging markers in premotor LRRK2 G2019S mutation carriersDolores Vilas, Lourdes Ispierto, Ramiro Álvarez, et al.
Pageof 17

Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
The Lancet. Neurology|September 18, 2010
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]Alex Iranzo, Francisco Lomeña, Heike Stockner, et al.
Journal of Neuroscience Research|March 21, 2014
Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's diseaseTeresa Botta-Orfila, Xavier Morató, Yaroslau Compta, et al.
Annals of Neurology|August 24, 2017
Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorderAlex Iranzo, Joan Santamaría, Francesc Valldeoriola, et al.
Parkinsonism & Related Disorders|February 13, 2021
Association of PSP phenotypes with survival: A brain-bank studyMar Guasp, Laura Molina-Porcel, Celia Painous, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 11, 2018
Unilateral pallidal stimulation for disabling dystonia due to Rasmussen's diseaseMar Carreño, Maria José Martí, Ibán Aldecoa, et al.
Journal of Neurology|November 9, 2014
Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's diseaseYaroslau Compta, Tony Valente, Josep Saura, et al.
Genes|April 28, 2023
Implementation of Exome Sequencing in Clinical Practice for Neurological DisordersMaría Isabel Alvarez-Mora, Laia Rodríguez-Revenga, Meritxell Jodar, et al.
Journal of Molecular Neuroscience : MN|June 7, 2012
Age at onset in LRRK2-associated PD is modified by SNCA variantsTeresa Botta-Orfila, Mario Ezquerra, Pau Pastor, et al.
Journal of Alzheimer'S Disease : JAD|November 5, 2016
Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1Mariateresa Buongiorno, Francesca Antonelli, Yaroslau Compta, et al.
Parkinsonism & Related Disorders|August 26, 2015
Clinical and imaging markers in premotor LRRK2 G2019S mutation carriersDolores Vilas, Lourdes Ispierto, Ramiro Álvarez, et al.
Pageof 17